In summary, while the immunomodulatory effects of NPs observed in this study including enhanced T-cell activation and correlations with cytokines such as IL-2, IL-6, and MCP-1 provide early mechanistic insights into key pathways, further investigation is needed to determine whether these outcomes are tumor-agnostic. This evidence concerns the gene CCL2 and neoplasm.